Delix Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Delix Therapeutics

Access the complete profile.

Delix Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	20 Authors Road Concord, MA 01742

Note: Revenues for privately held companies are statistical evaluations.


Delix Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Delix Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Delix Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Delix Therapeutics Annual Revenue and Growth Rate

Delix Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Delix Therapeutics's revenues are gauged from an analysis of company filings.

Delix Therapeutics's Income Statement (based on Industry Averages)

Delix Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Delix Therapeutics is developing and marketing. Delix Therapeutics doesn't have any recent trademark applications, indicating Delix Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DELIX THERAPEUTICS Pharmaceutical products for the treatment of mental health conditions, namely, depression, anxiety, mood disorders, posttraumatic stress, cognitive, and neurodegenerative disorders; pharmaceutical products in the field of mental health diseases and disorders, namely, depression, anxiety, mood disorders, post-traumatic stress, cognitive, and neurodegenerative disorders	05/12/2021
X Pharmaceutical products for the treatment of health and mental health; pharmaceutical products in the fields of health and mental health diseases and disorders	05/12/2021

See all trademarks and details in the Full Report.

Market Share of Delix Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Delix Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Delix Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SUMITOMO PHARMA AMERICA	Marlborough, MA	100
OXFORD BIOMEDICA SOLUTIONS	Bedford, MA	7
DELIX THERAPEUTICS	Concord, MA	4
SINOVENT PHARMACEUTICALS	Concord, MA	2
IMV	Sherborn, MA	2
ALLORION THERAPEUTICS	Natick, MA	2

Future Competition: Delix Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Delix Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)